A Review on AI-Powered Multi-Disease Prediction System

Abstract

Stroke remains a leading cause of mortality and long-term disability worldwide. Early identification of risk factors is critical for preventive intervention. This paper proposes Medinox, an AI-powered diagnostic screening system designed to assess stroke risk based on clinical parameters and lifestyle modifiers. Utilizing machine learning algorithms, the system processes patient data including blood pressure, BMI, glucose levels, and smoking status to provide a categorized risk assessment. The system features a responsive web interface for real-time reporting and personalized lifestyle recommendations. Preliminary testing indicates that the AI-driven approach offers a scalable solution for preliminary medical screening, bridging the gap between home monitoring and clinical diagnosis. In addition to these capabilities, Medinox incorporates data preprocessing techniques such as normalization and handling of missing values to ensure more accurate predictions. Multiple machine learning models, including logistic regression, decision trees, and ensemble methods, are evaluated to identify the most effective approach for stroke risk classification. The system is designed with user accessibility in mind, allowing individuals with minimal technical knowledge to input their health data and receive instant feedback. Furthermore, the platform emphasizes preventive healthcare by suggesting actionable lifestyle changes such as improved diet, increased physical activity, and smoking cessation. Future enhancements may include integration with wearable health devices for continuous monitoring and the use of advanced deep learning models to further improve prediction accuracy and reliability.

Introduction

The text describes a stroke-risk early detection system called Medinox, an AI-powered health screening platform designed to identify stroke risk before emergency conditions occur. It addresses a major healthcare gap where periodic clinical visits often miss gradual worsening of risk factors such as hypertension, diabetes, and lifestyle habits. Medinox uses user-provided physiological, biometric, and behavioral data to generate an automated, structured risk assessment.

The system performs early risk stratification by analyzing combined health indicators rather than isolated values, categorizing users into Low, Moderate, or High risk. It provides actionable insights such as lifestyle modifications and clinical warnings, and generates a professionally formatted, digitally verified medical report to assist doctor consultations.

The architecture includes:

• A data input module for vital signs, biomarkers, and lifestyle history
• An AI screening engine that correlates risk factors using weighted logic
• A risk scoring system that dynamically adjusts severity levels
• A report generation module producing clinical-grade PDFs

The server module processes data through ML models, supports preprocessing, secure handling of health data, and may use LLMs for explanation of results. It also ensures compliance through encryption and data masking.

Methodology involves four stages: data collection, preprocessing and normalization, weighted risk computation, and automated report generation. The system emphasizes lifestyle-related risk factors (like smoking and alcohol use) alongside clinical metrics.

Key advantages include faster risk detection, improved interpretation of health trends, user-friendly visualization, and instant clinical summaries. Future enhancements include IoT wearable integration, deep learning-based long-term disease prediction, expansion to other chronic diseases, and telemedicine integration for immediate care.

Conclusion

The development and implementation of the Medinox Al-Powered Diagnostic Screening System represent a significant step forward in the democratization of preventative healthcare. By successfully addressing the critical need for an accessible, intelligent, and highly interpretative health tool, the system provides a robust solution to the \"screening gap\" currently present in vascular health management. Through the synthesis of clinical vital signs-such as blood pressure and glucose-with behavioural \"Primary Risk Modifiers\" like smoking and alcohol consumption, the platform offers a far more holistic and accurate view of stroke risk than traditional, isolated monitoring methods. The technical architecture proves that modern web technologies, combined with weighted Al logic, can be leveraged to create a \"patient-first\" diagnostic experience. Key takeaways from the system\'s performance include: Proactive Advocacy: The system shifts the user from being a passive data-logger to an informed health advocate who understands the \"Priority\" level of their condition. Clinical Communication: By generating an ISO-compliant, digitally verified report, Medinox facilitates better communication between patients and physicians, ensuring that professional consultations are data-driven and concise. Early Intervention: The system\'s ability to flag moderate risks in asymptomatic or young patients (as seen in the Case Study of Patient MNX-0003) demonstrates its potential to prevent emergency events before they occurIn conclusion, Medinox fosters a culture of proactive health management. It demonstrates that while Al cannot replace the clinical judgment of a doctor, it can serve as a powerful \"early-warning system\" that encourages timely medical intervention, potentially saving lives through the power of data-driven awareness and early detection.

References

[1] Ram Babu, D., et al. (2026). \"Disease Prediction Hub – A Multi-Disease Machine Learning Screening System with FastAPI Backend and Groq-Powered Health Chatbot.\" International Journal of Engineering Research & Technology (IJERT). Paper ID: IJERTV15IS040796. [2] Sireesha, M., et al. (2026). \"Automated Prediction of Multiple Diseases through Deep Learning Models.\" International Journal of Emerging Research in Engineering and Technology. [3] Bamini, A., et al. (2025). \"Mnetgidd: a heuristic-oriented segmentation and deep learning multi-disease detection model for gastrointestinal tracts.\" International Journal of Systematic Innovation. [4] Nandalwar, J. I., et al. (2025). \"A systematic meta-analysis on the role of artificial intelligence and machine learning in detection of gynaecological disorders.\" International Journal of Systematic Innovation. [5] AccScience Publishing (2025). \"Artificial intelligence within medical diagnostics: A multi-disease perspective.\" AI in Health Journal. [6] DeGroat, W., et al. (2024). \"Discovering biomarkers associated and predicting cardiovascular disease with high accuracy using a novel nexus of machine learning techniques for precision medicine.\" Scientific Reports. DOI: 10.1038/s41598-023-50600-8. [7] Chunduru, A., et al. (2024). \"Multi Chronic Disease Prediction System Using CNN and Random Forest.\" SN Computer Science. DOI: 10.1007/s42979-023-02521-6. [8] Rehman, A. (2024). \"Multiple Disease Prediction System using Machine Learning.\" Journal of Informatics Electrical and Electronics Engineering (JIEEE). DOI: 10.54060/a2zjournals.jieee.110. [9] Papachristou, P., et al. (2024). \"Evaluation of an artificial intelligence-based decision support for detection of cutaneous melanoma in primary care-a prospective, real-life, clinical trial.\" British Journal of Dermatology. DOI: 10.1093/bjd/ljae021. [10] Lyakhova, U., & Lyakhov, P. (2024). \"Systematic review of approaches to detection and classification of skin cancer using artificial intelligence.\" Computers in Biology and Medicine. DOI: 10.1016/j.compbiomed.2024.108742.

Copyright

Copyright © 2026 Prof. Asha Gaikar, Gaurav Sonpasare, Raj Borhade, Shubham Ghotane, Sujal Rathod. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.